Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flexible-dose paliperidone ER in acute schizophrenia exacerbation
2006-006642-34Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of paliperidone in schizophrenia, sponsored by Janssen Pharmaceutical. Primary endpoint: Treatment response. Started Apr 2007; status: completed.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2006-006642-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006642-34.